Oxford Biomedica plc (OXB) Ordinary 50p
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
334.50p
339.50p
455.00p
£354.88 million
334.50p
326.00p
232.50p
n/a
8.00p (2.45%) Previous:
8.00p
1,499
n/a
3,000
Performance
| 1 week 1W | 7.21% | 1 year 1Y | 2.76% |
|---|---|---|---|
| 1 month 1M | 13.39% | 2 years 2Y | 27.52% |
| 3 months 3M | 13.39% | 3 years 3Y | 31.8% |
| 6 months 6M | 21.75% | 5 years 5Y | 56.27% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Revenue (£m) | 128.80 | 89.54 |
| Profit before tax (£m) | (47.27) | (188.53) |
| Adjusted EPS (p): | (41.75) | (163.11) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Oxford Biomedica reports first-half revenue growth
23 September 2024 11:16
-
Oxford Biomedica still expecting small loss after solid first half
8 August 2024 12:38
-
Oxford Biomedica appoints new finance chief
17 July 2024 09:51
-
Block Listing Application
5 June 2025 07:00
-
OXB Launches Advisory Board
3 June 2025 07:00
-
Total Voting Rights
2 June 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.